GEMI · Gemini Space Station, Inc. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on GEMI. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About GEMI · Gemini Space Station, Inc.
Gemini Space Station, Inc. operates a cryptocurrency platform in the United States and internationally. The company offers Gemini, a platform that enables users to trade, custody, and earn in a range of digital assets and offerings; Gemini ActiveTrader for advanced charting, multiple order types, and the ability to monitor and execute in multiple markets; and Gemini Derivatives to trade perpetual contracts with cross-collateralization for risk and capital management. It also provides Gemini Prediction for trading event contracts; custody solutions; and Gemini Credit Card for users to earn crypto rewards. The company serves institutional investors, including asset managers, hedge funds, proprietary trading firms, and corporations, as well as individual retail users. Gemini Space Station, Inc. was founded in 2014 and is based in New York, New York.
Live Quote
SELL (score -7) · 12-1 mom -83.5% · RSI 44.3 · below_both · -86.4% from high
Targets blend Wall Street consensus (9 analysts: low $4.00 / mean $6.58 / high $10.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
Investigation triggered by a reported cluster of 4 Form 4 filings in 14 days. Upon detailed review of each filing, all 4 transactions on June 16, 2026 (Esposito, Jaitly, Filipakis, Durham) were RSU grants under the Non-Employee Director Compensation Policy — acquisition code 'A' at $0 consideration — not open-market purchases. There is no genuine insider buy cluster. The business has pivoted from a pure crypto exchange toward prediction markets, credit cards, and derivatives; it is deeply unprofitable (negative margins), highly levered (D/E ~108%), and the stock has collapsed ~81% YTD after IPO pricing near $25-26. The Winklevoss twins' $100M investment at ~$14 in May 2026 provides a paper anchor but no market-level signal. Securities class action litigation over IPO disclosures is active. Earnings on August 10 are the next scheduled catalyst, with IV elevated (~97-110% ATM), making income strategies more defensible than long equity.
Recent news from TradeBytes mentioning GEMI
Articles from the sister news site that name this ticker. Independent of the AI pipeline's research.